Intravenously administered rituximab induces remission of EBV associated non Hodgkin lymphoma confined to the brain in a patient after allogeneic stem cell transplantation.

MLA

Stuhler, G., et al. “Intravenously Administered Rituximab Induces Remission of EBV Associated Non Hodgkin Lymphoma Confined to the Brain in a Patient after Allogeneic Stem Cell Transplantation.” Haematologica, vol. 91, no. 3, Mar. 2006, p. ECR01. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=16533728&authtype=sso&custid=ns315887.

APA

Stuhler, G., Knop, S., Topp, M. S., Kröber, S. M., Ernemann, U., Herrlinger, U., Einsele, H., Kanz, L., & Hebart, H. (2006). Intravenously administered rituximab induces remission of EBV associated non Hodgkin lymphoma confined to the brain in a patient after allogeneic stem cell transplantation. Haematologica, 91(3), ECR01.

Chicago

Stuhler, G, S Knop, M S Topp, S M Kröber, U Ernemann, U Herrlinger, H Einsele, L Kanz, and H Hebart. 2006. “Intravenously Administered Rituximab Induces Remission of EBV Associated Non Hodgkin Lymphoma Confined to the Brain in a Patient after Allogeneic Stem Cell Transplantation.” Haematologica 91 (3): ECR01. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=16533728&authtype=sso&custid=ns315887.